Prenetics (NASDAQ:PRE) is a leading health sciences company committed to advancing both consumer and clinical health. The company operates through various initiatives, including IM8, a health and wellness brand, and Europa, a top sports distribution company in the USA. Its clinical division, Insighta, is a joint venture focused on multi-cancer early detection technologies, while ACT Genomics specializes in comprehensive genomic profiling of solid tumors. Additionally, CircleDNA offers extensive DNA testing using next-generation sequencing. Prenetics aims to enhance global health through science, with each of its units working synergistically to make a significant impact.